Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: Objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT

Brain and Nerve

Volumn 58, Issue 1, 2006, Pages 29-37

  Sakai, Toshiyuki ^a   Kuzuhara, Shigeki ^b  

^a SAISEIKAI MATSUSAKA GENERAL HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

123I IMP SPECT; Cognitive function and duration of illness; Parkinson's disease (PD); Posterior cingulate cortex; Stereotactic extraction estimation (SEE)

Indexed keywords

IOFETAMINE I 123; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; COGNITION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LEWY BODY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUDENT T TEST;

AGED; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION; FEMALE; HUMANS; IOFETAMINE; MALE; MIDDLE AGED; PARKINSON DISEASE; REGIONAL BLOOD FLOW; STEREOTAXIC TECHNIQUES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 32844461043     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aarsland D, Larsen JP, Cummings JL, Laake K: Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56: 595-601, 1999
2. Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AAF: Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47: 462-466, 1996
3. Antonini A, Notaris RD, Benti R, Gaspari DD, Pezzoli G: Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 22: 45-46, 2001
4. Borght TV, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE: Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 38: 797-802, 1997
5. Brun A, Gustafson L: Distribution of cerebral degeneration in Alzheimer's disease. Arch Psychiat Nervenkr 223: 15-33, 1976
6. Brun A, Englund E: Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 5: 549-564, 1981
7. Defebvre L, Lecouffe P, Destee A, Houdart P, Steinling M: Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand 92: 235-241, 1995
8. Hakim AM, Mathieson G: Dementia in Parkinson disease: a neuropathologic study. Neurology 29: 1209-1214, 1979
9. Hughes AJ, Daniel SE, Kilford L, Lees AL: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992
10. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41: 1155-1162, 2000
11. Lancaster JL, Rainey LH, Summerlin JL, Freitas CS, Fox PT, Evans AE, Toga AW, Mazziotta JC: Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp 5: 238-242, 1997
12. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV: Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131, 2000
13. Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M: Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (Berl) 100: 285-290, 2000
14. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH: An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872-877, 1994
15. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36: 1238-1248, 1995
16. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42: 85-94, 1997
17. Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, Kumazaki T: Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nuc Med 17: 289-295, 2003
18. Mizumura S, Nakagawara J, Takahashi M, Kumita S, Cho K, Nakajo H, Toba M, Kumazaki T: Three-dimensional display in staging hemodynamic brain ischemia for JET study: objective evaluation using SEE analysis and 3D-SSP display. Ann Nuc Med 18: 13-21, 2004
19. Salmon E, Maquet P, Sadzot B, Degueldre Ch, Lemaire Ch, Franck G: Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. Acta Neurol Belg 91: 288-295, 1991
20. Sutherland RJ, Whishaw IQ, Kolb B: Contributions of cingulate cortex to two forms of spatial learning and memory. J Neurosci 8: 1863-1872, 1988
21. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers, New York, 1988
22. Vogt BA, Van Hoesen GW, Vogt LJ: Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol(Berl)80: 581-589, 1990